RNA Diagnostics

Profile

RNA Diagnostics is a commercial stage molecular diagnostics company. VERIDAPT DX™ enables precision oncology through prediction of on-treatment tumor response. VERIDAPT DX™ is validated in > 1000 patients in prospective and retrospective clinical studies. No other biomarkers are positioned to accurately predict patient response within 5 weeks of initiation of neoadjuvant cancer treatment. Oncologists use VERIDAPT DX™ to optimize treatments in real time. VERIDAPT DX™ enables Improved outcomes for patients and cost savings for payers.

Website

rnadiagnostics.com

Contact


Event details

Date: October 18 - 23, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

<?php global $lang_id; switch ($lang_id) { case "fr": echo 'Total de 15'; break; case "pt-br": echo 'Total de 15'; break; case "es": echo 'Total de 15'; break; case "ja": echo '15 合計'; break; case "ko": echo '15 총계'; break; case "en": default: echo '15 in total'; break; } ?>